855264-88-9

Upstream product

• 860594-97-4 3,5-dibromo-4-(4-methoxy-phenoxy)-benzonitrile 
• 98137-96-3 1,3-dibromo-2-iodo-5-nitrobenzene 
• 28818-54-4 3,5-dibromo-4-(4-methoxy-phenoxy)-aniline 
• 150-76-5 4-methoxy-phenol 
• 861787-50-0 3,5-dibromo-4-iodo-benzaldehyde 
• 60962-93-8 1-(2,6-dibromo-4-nitro-phenoxy)-4-methoxy-benzene 

Downstream Products

• 14936-60-8 3,5-dibromo-4-(4-methoxy-phenoxy)-trans-cinnamic acid 
• 2448-44-4 3,5-dibromo-4-(3,5-dibromo-4-methoxy-phenoxy)-trans-cinnamic acid 
• 858217-49-9 2,3-dibromo-3-[3,5-dibromo-4-(3,5-dibromo-4-methoxy-phenoxy)-phenyl]-propionic acid 
• 1225032-65-4 3,5-dibromo-4-(4-methoxyphenoxy)benzaldehyde oxime 
• 1225032-04-1 2-(((3,5-dibromo-4-(4-hydroxy-3-(piperidin-1-yl sulfonyl)phenoxy)benzylidene)amino)oxy)propanoic acid 
• 1225032-43-8 ethyl 2-(((3,5-dibromo-4-(4-methoxy-3-(piperidin-1-yl sulfonyl)phenoxy)benzylidene)amino)oxy)propanoate 
• 1225032-68-7 Ethyl 2-(((3,5-dibromo-4-(3-(chlorosulfonyl)-4-methoxy phenoxy)benzylidene)amino)oxy)propanoate 
• 1225031-94-6 2-(((3,5-dibromo-4-(3-(4-chlorobenzoyl)-4-hydroxy phenoxy)benzylidene)amino)oxy)propan oic acid 
• 1225032-38-1 Ethyl 2-(((3,5-dibromo-4-(3-(4-chlorobenzoyl)-4-hydroxy phenoxy)benzylidene)amino)oxy)propanoate 
• 1225032-66-5 ethyl 2-(((3,5-dibromo-4-(4-methoxy phenoxy)benzylidene)amino)oxy)propanoate 
• 1225032-67-6 ethyl 2-(((3,5-dibromo-4-(3-((4-chlorophenyl)(hydroxy)methyl)-4-hydroxyphenoxy)benzylidene)amino)oxy)propanoate 
• 1225032-37-0 Ethyl 2-(((3,5-dibromo-4-(3-(4-chlorobenzoyl)-4-methoxy phenoxy)benzylidene)amino)oxy)propanoate 

Relevant academic research and scientific papers

THYROID RECEPTOR LIGANDS

The present invention relates to novel compounds of general formula (I) which are thyroid receptor ligands and are preferably selective for the thyroid hormone receptor beta (TR-Beta). Further, the present invention relates to processes of preparing such

THYROID RECEPTOR LIGANDS

The present invention relates to novel compounds of general formula (I) which are thyroid receptor ligands and are preferably selective for the thyroid hormone receptor beta (TR-Beta). Further, the present invention relates to processes of preparing such compounds, their tautomeric forms, novel intermediates involved in their synthesis, their pharmaceutically acceptable salts, methods for using such compounds and pharmaceutical compositions containing them.